What Is Bioventus Inc. (BVS) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Bioventus Inc.'s intrinsic value is estimated at $11.04, presenting a divided outlook at the current price of $12.07. With an average implied return of -8.5% across a split 2–6 (bull–bear) consensus, the model spread of +192.7% underscores analytical uncertainty. Notably, Regime Cross sees the most upside at +99.3% (fair value: $24.05), while Bayesian DCF is the most conservative at -93.4% ($0.79). The spread between these extremes — +192.7% — reveals how different analytical frameworks can reach starkly different conclusions.
What Do the Models Say About BVS?
11 of 13 models are currently active for BVS. Of these, 4 models suggest upside while 7 models suggest overvaluation. The Bayesian DCF estimates BVS's intrinsic value at $0.79, implying -93.4% downside from the current price. See which stocks rank higher →
How Does BVS Rank in Surgical & Medical Instruments & Apparatus?
Among 111 Surgical & Medical Instruments & Apparatus stocks, BVS ranks #51 by Quality of Company score. CirclFi's QOC score of 6.7/10 evaluates 32 fundamental signals. A score of 6.7 indicates above-average quality.
See all Most Undervalued Surgical & Medical Instruments & Apparatus Stocks →
Bioventus Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is BVS a Value Trap?
CirclFi's Value Trap algorithm assigns BVS a score of 24/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
11 of 13 models are active for Bioventus Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Bioventus Inc.'s fundamental quality profile registers 6.7/10. This respectable score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +192.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every BVS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across BVS's 11 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad